Shares of Infinity Natural Resources jumped almost 11% in their NYSE debut, valuing the oil and natural gas producer at $1.3B. The listing ...

(Reuters) -Shares of Maze Therapeutics rose nearly 1% in their Nasdaq debut on Friday, valuing the kidney disease drug developer at $690.37 million. The company's shares opened at $16.12 apiece, ...

Maze Therapeutics (NASDAQ:MAZE) shares were trading largely flat following a $140M initial public offering. Shares of the kidney disease drug developer opened at $16 per share after being priced at ...

Listen to this article When Three Dog Night takes the stage May 4 at The Dome, the 1970s rock band will help open a new chapter in live performances at the Virginia Beach Oceanfront that it closed ...

Smithfield Foods launched its initial public offering of stock this Tuesday (Jan. 28), selling 26 million shares at $20 each ...

IPO experts are expecting more companies to go public this year than last year, and restaurants including Panera and Fogo de ...

Smithfield Foods' IPO priced below expectations, reflecting volatile earnings and numerous risks, making the stock appear ...

Hedgeye recommends Smithfield Foods (SFD) as a long idea post-IPO, citing potential 50% upside and undervaluation compared to ...

The big story of the day remains the Federal Reserve, which concludes its two-day FOMC meeting today and will announce its rate decision at 2:00pm New York time and then hold a press conference with ...

KEY TAKEAWAYS Smithfield Foods stock edged lower in its trading debut Tuesday after the U.S. pork giant priced shares below ...

NASDAQ, S&P, and Dow Industrials, all key major US markets players, were in green, showing an upward trend on Tuesday, a ...

Smithfield Foods, Inc., an American food company with a leading position in packaged meats and fresh pork products, debuted ...